These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33062188)
1. Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18. Schoeder CT; Mahardhika AB; Drabczyńska A; Kieć-Kononowicz K; Müller CE ACS Med Chem Lett; 2020 Oct; 11(10):2024-2031. PubMed ID: 33062188 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18. Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723 [TBL] [Abstract][Full Text] [Related]
3. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity. Mahardhika AB; Załuski M; Schoeder CT; Boshta NM; Schabikowski J; Perri F; Łażewska D; Neumann A; Kremers S; Oneto A; Ressemann A; Latacz G; Namasivayam V; Kieć-Kononowicz K; Müller CE J Med Chem; 2024 Jun; 67(12):9896-9926. PubMed ID: 38885438 [TBL] [Abstract][Full Text] [Related]
4. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18. Neumann A; Engel V; Mahardhika AB; Schoeder CT; Namasivayam V; Kieć-Kononowicz K; Müller CE Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365486 [TBL] [Abstract][Full Text] [Related]
5. Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders. Frankowska M; Wydra K; Suder A; Zaniewska M; Gawliński D; Miszkiel J; Furgała-Wojas A; Sałat K; Filip M; Müller CE; Kieć-Kononowicz K; Kotańska M Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240392 [TBL] [Abstract][Full Text] [Related]
6. The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects. Kotańska M; Kubacka M; Bednarski M; Nicosia N; Szafarz M; Jawień W; Müller CE; Kieć-Kononowicz K Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451896 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds. Schoeder CT; Hess C; Madea B; Meiler J; Müller CE Forensic Toxicol; 2018; 36(2):385-403. PubMed ID: 29963207 [TBL] [Abstract][Full Text] [Related]
8. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold. Rempel V; Volz N; Gläser F; Nieger M; Bräse S; Müller CE J Med Chem; 2013 Jun; 56(11):4798-810. PubMed ID: 23679955 [TBL] [Abstract][Full Text] [Related]
9. GPR18 and GPR55-related Ligands Serving as Antagonists or Agonists: Current Situation, Challenges and Perspectives. Zhang L; Fang Y; Hang S; Wu W; Sheng R; Guo R Med Chem; 2023; 19(9):838-847. PubMed ID: 37038675 [TBL] [Abstract][Full Text] [Related]
10. Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. McHugh D; Page J; Dunn E; Bradshaw HB Br J Pharmacol; 2012 Apr; 165(8):2414-24. PubMed ID: 21595653 [TBL] [Abstract][Full Text] [Related]
11. Molecular and functional interaction between GPR18 and cannabinoid CB Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711 [TBL] [Abstract][Full Text] [Related]
12. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Guerrero-Alba R; Barragán-Iglesias P; González-Hernández A; Valdez-Moráles EE; Granados-Soto V; Condés-Lara M; Rodríguez MG; Marichal-Cancino BA Front Pharmacol; 2018; 9():1496. PubMed ID: 30670965 [No Abstract] [Full Text] [Related]
13. THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner. Kolbe MR; Hohmann T; Hohmann U; Ghadban C; Mackie K; Zöller C; Prell J; Illert J; Strauss C; Dehghani F Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802282 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Hess C; Schoeder CT; Pillaiyar T; Madea B; Müller CE Forensic Toxicol; 2016; 34():329-343. PubMed ID: 27429655 [TBL] [Abstract][Full Text] [Related]
15. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877 [TBL] [Abstract][Full Text] [Related]
16. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [TBL] [Abstract][Full Text] [Related]
17. GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries. Kozłowska H; Malinowska B; Baranowska-Kuczko M; Kusaczuk M; Nesterowicz M; Kozłowski M; Müller CE; Kieć-Kononowicz K; Schlicker E Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163351 [TBL] [Abstract][Full Text] [Related]
18. Characterization of structurally novel G protein biased CB Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808 [TBL] [Abstract][Full Text] [Related]